<P>A self-sufficient two-in-one whole-cell biocatalyst combining ketoreductase and cofactor regenerating enzyme activities has been developed and successfully utilized to synthesize (<I>R</I>)-3-quinuclidinol with an increase in the reaction rate of 3-fold over the native enzymes at low biocatalysts loading (∼1.65%), excellent enantioselectivity, impressive substrate concentration of 486 g L<SUP>-1</SUP>, and high space-time yield of (<I>R</I>)-3-quinuclidinol up to 1505.5 g L<SUP>-1</SUP> d<SUP>-1</SUP>, which was the highest ever reported. These results demonstrated that the newly developed self-sufficient biocatalyst could be useful for synthetic and industrial application in synthesis of (<I>R</I>)-3-quinuclidinol, essential for the production of solifenacin, revatropate, and aclidinium, with better clinical outcome than those currently available.</P><BR>[FIG OMISSION]</BR>